Skip to main content

Biolife Solutions Inc

BLFS
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0000834365

No open-market purchases or sales by Biolife Solutions Inc insiders were filed in the last 90 days; 216 institutions reported holding it in 13F filings for Q2 2026, worth $1.40B in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Biolife Solutions Inc changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of BLFS: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders160174+14
Shares36.9M38.4M+1.56M (+4.2%)
Value$509.1M$873.9M+$364.7M (+71.6%)

New holders (23)

Institutions that held Biolife Solutions Inc at the end of Q3 2022 but not at the end of Q2 2022.

Sold out (9)

Institutions that held Biolife Solutions Inc at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of BLFS in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Renaissance Technologies LLC179,200$2.48M
HighTower Advisors, LLC93,767$1.29M
Qube Research & Technologies Ltd57,976$801.0K
Versor Investments LP26,300$363.0K
Two Sigma Advisers, LP18,800$260.0K
Simplex Trading, LLC567$7.00K
Aquatic Capital Management LLC200$3.00K
Total Clarity Wealth Management, Inc.235$3.00K
Prospera Financial Services Inc91$1.00K